CAS No.
[65646-68-6(Unlabeled)]
Synonyms
(2E,4E,6E,8E)-N-(4-hydroxyphenyl-2,3,5,6-d4)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Fenretinide-d4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Fenretinide-d4 usage and description
Fenretinide D4 is a synthetic retinoid, which is a derivative of vitamin A. It is used in the treatment of cancer and other diseases. The drug is known to induce apoptosis, or programmed cell death, in cancer cells, which makes it a promising option for cancer therapy.
Fenretinide D4 works by binding to retinoic acid receptors (RARs), which are proteins found in the nucleus of cells. This binding activates a series of signaling pathways that ultimately lead to the induction of apoptosis in cancer cells. Fenretinide D4 has also been shown to have anti-inflammatory and anti-angiogenic properties, which means it can inhibit the growth of new blood vessels that tumors need to survive.
In terms of chemical information, Fenretinide D4 is a stable isotopic labeled form of fenretinide, which means it is a modified version of the original drug. The molecular formula of Fenretinide D4 is C26H35D4NO2, and its chemical name is 4-oxo-N-(4-hydroxyphenyl)retinamide-d4.
Overall, Fenretinide D4 is a promising drug for the treatment of cancer and other diseases. Its ability to induce apoptosis in cancer cells and inhibit the growth of new blood vessels make it a valuable option for cancer therapy.
